Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors | MicrobiomeTrials← Back to trialsNCT00029445
Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
RecruitingOBSERVATIONAL
Trial Details
Enrollment target: 400 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
KSHV Inflammatory Cytokine Syndrome (KICS)KSHVHHV-8
Background:
\- KSHV inflammatory cytokine syndrome (KICS) is a newly recognized disease caused by Kaposi sarcoma-associ…
Bethesda, United StatesEst. completion Dec 31, 2028
AIDS-related LymphomaHIV Infection
The goal of this clinical trial is to evaluate the efficacy and safety of different antiretroviral therapy (ART) strateg…
Shanghai, ChinaEst. completion Jul 2028
Recruiting
Chronic Hepatitis B Infection
France is a low-endemicity country for hepatitis B virus (HBV) infection. In 2016, the prevalence of chronic HBV infecti…
Créteil, FranceEst. completion Sep 1, 2029